Literature DB >> 25543522

Nonalcoholic fatty liver disease (NAFLD) without insulin resistance: Is it different?

Shivaram Prasad Singh1, Bijay Misra2, Sanjib Kumar Kar2, Manas Kumar Panigrahi2, Debasis Misra2, Pallavi Bhuyan3, Kaumudee Pattnaik3, Chudamani Meher4, Omprakash Agrawal4, Niranjan Rout5, Manorama Swain6.   

Abstract

BACKGROUND AND AIMS: Nonalcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of insulin resistance [IR]. However, a significant proportion of NAFLD patients are devoid of IR. Is NAFLD sans IR a different entity? The aim of the study was to compare the anthropometric, metabolic, biochemical, ultrasonography, and histological profile of NAFLD patients with and without IR.
METHODS: Retrospective analyses of 336 NAFLD patients diagnosed during the last two years was done. Patients without IR were compared with those with IR.
RESULTS: Out of 336 patients, 153 [45.53%] were without IR. Although age, gender, BMI and transaminase levels were comparable, significantly higher proportion of patients in non-IR group were non-obese [43.14% vs. 25/14%; P=0.0005], and had mild fatty change on ultrasonography; [78.43% vs. 67.21%; P=0.022]. Higher proportion of them had elevated transaminases; [67.97% vs. 56.83%; P=0.036]. Serum triglyceride [178.52±78.78 vs. 204.86±94.72 mg/dl; P=0.02], FBG [85.39±13.80 vs. 98.93±31.56 mg/dl; P=0.00], PGBG [123.76±36.77 vs. 148.07±64.67m g/dl; P=0.00], and serum insulin [6.33±2.18 vs. 15.39±12.56 μIU/ml; P=0.00] were significantly lower in patients without IR. Although there was no difference in histology, interestingly fibrosis was seen in one third of patients despite absence of IR.
CONCLUSION: Nearly half of our NAFLD population was without IR; one third of them had significant fibrosis. NAFLD is probably a heterogeneous disease and IR is not the sole factor responsible for NAFLD; further studies are needed to find out other possible etiological factors.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25543522     DOI: 10.1016/j.clinre.2014.08.014

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  12 in total

Review 1.  The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.

Authors:  Mithun Sharma; Shasikala Mitnala; Ravi K Vishnubhotla; Rathin Mukherjee; Duvvur N Reddy; Padaki N Rao
Journal:  J Clin Exp Hepatol       Date:  2015-02-16

2.  Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD).

Authors:  Cathrin Sellmann; Cheng Jun Jin; Anna Janina Engstler; Jean-Pascal De Bandt; Ina Bergheim
Journal:  Eur J Nutr       Date:  2016-08-05       Impact factor: 5.614

3.  Biochemical Profile of Nonalcoholic Fatty Liver Disease Patients in Eastern India with Histopathological Correlation.

Authors:  Manorama Swain; Preetam Nath; Prasant Kumar Parida; Jimmy Narayan; Pradeep Kumar Padhi; Girish Kumar Pati; Ayaskanta Singh; Bijay Misra; Debasis Misra; Sanjib Kumar Kar; Manas Kumar Panigrahi; Chudamani Meher; Omprakash Agrawal; Niranjan Rout; Kaumudee Pattnaik; Pallavi Bhuyan; Pramila Kumari Mishra; Shivaram Prasad Singh
Journal:  Indian J Clin Biochem       Date:  2016-09-03

4.  Clinical, anthropometric, biochemical and histological character of nonalcoholic fatty liver disease without Insulin Resistance.

Authors:  Shahinul Alam; Kamrul Anam; Saiful Islam; Golam Mustafa; Ayub Al Mamun; Nooruddin Ahmad
Journal:  J Clin Exp Hepatol       Date:  2018-06-20

Review 5.  Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators.

Authors:  Elena Piccinin; Gaetano Villani; Antonio Moschetta
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-03       Impact factor: 46.802

6.  Biopsy Proven Fibrosis in Non-Alcoholic Fatty Liver Disease: An Analysis of Risk Factors.

Authors:  Kaumudee Pattnaik; Pallavi Bhuyan; Ayaskant Singh; Shivaram P Singh; Preetam Nath; Sanjib Kar; Bijay Misra; Jayashree Rath
Journal:  J Clin Exp Hepatol       Date:  2018-01-08

7.  The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice.

Authors:  Beihui He; Liyan Wu; Wei Xie; Yitong Shao; Jianping Jiang; Zhenzhong Zhao; Maoxiang Yan; Zhiyun Chen; Dawei Cui
Journal:  BMC Immunol       Date:  2017-06-24       Impact factor: 3.615

8.  Rapid Recapitulation of Nonalcoholic Steatohepatitis upon Loss of Host Cell Factor 1 Function in Mouse Hepatocytes

Authors:  Shilpi Minocha; Dominic Villeneuve; Viviane Praz; Catherine Moret; Maykel Lopes; Danièle Pinatel; Leonor Rib; Nicolas Guex; Winship Herr
Journal:  Mol Cell Biol       Date:  2019-02-15       Impact factor: 4.272

9.  Hepatic lymphocytes involved in the pathogenesis of pediatric and adult non-alcoholic fatty liver disease.

Authors:  Victoria Cairoli; Elena De Matteo; Daniela Rios; Carol Lezama; Marcela Galoppo; Paola Casciato; Eduardo Mullen; Cecilia Giadans; Gustavo Bertot; María Victoria Preciado; Pamela Valva
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

Review 10.  Nonalcoholic Fatty Liver Disease in South Asia.

Authors:  Girish K Pati; Shivaram P Singh
Journal:  Euroasian J Hepatogastroenterol       Date:  2016-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.